Real life experience of Belimumab therapy in Lupus Nephritis: A Case Report
Author(s): S Elamin
Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disorder that is challenging to diagnose and manage (1). This inflammatory condition can affect multiple organs with potential for significant morbidity and mortality. The hallmark feature of the disease process is the formation of antinuclear autoantibodies, and deposition of immune complexes into tissues, contributing to organ inflammation and damage (2). Cytokines also play an important role, with B-lymphocyte stimulator (BLys), essential for B cell survival, generating a lot of interest in recent times